Brigit Biofarmaka Teknologi Tbk. vs Sarimelati Kencana Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 179.3K 24h volume), while Sarimelati Kencana Tbk. trades at Rp181 (market cap 549.98B, 303.7K 24h volume). The key difference: Sarimelati Kencana Tbk. is far larger — about 3.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Sarimelati Kencana Tbk. is more actively traded (303.7K versus 179.3K). Which is the better fit depends on your goals.
| OBAT | PZZA | |
|---|---|---|
Market Cap | 164.65B | 549.98B |
Volume | 179.3K | 303.7K |
Lot | 1.79K | 3.04K |
Turnover | 42.41M | 55.19M |
Average Price | 236.51 | 181.72 |
Value | 42.41M | 55.19M |
Indicative Equilibrium Price | 242 | — |
Indicative Equilibrium Volume | 500 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Sarimelati Kencana Tbk. (the Company) was established based on Notarial Deed No. 132 dated December 16, 1987 of Lieke Lianadevi Tukgali, S.H.
Read more on PZZA →